Months after partnering with Sanofi on infectious diseases, Germany-based Evotec formed another significant partnership with Novo Nordisk.

As part of the company’s fourth-quarter 2017 earnings report, Paris-based Sanofi released a pipeline update showing it plans to halt several mid-stage drug programs.